miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...
AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), ...
The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12.89 billion in 2025 to USD 25.38 billion by 2033, growing at a CAGR of 8.84 ...
“Despite industry challenges, Samsung Biologics is well positioned to kick-start a new phase of growth in 2025 with the ...
Innovent Biologics, a biopharmaceutical company based in Shuzou, China, has agreed a collaboration with Roche to develop ...
The "Antibody Drug Conjugates Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering.World revenue for the Antibody Drug Conjugates Market is set to surpass US$16 billion in 2025 ...
SEOUL, South Korea, Jan. 17, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEO James Park) announced on January 16 that it had ...
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback